Hepatic steatosis in liver transplant recipients: Risk factors and impact on outcome.

被引:0
|
作者
Sterling, RK [1 ]
Gennings, C [1 ]
Shih, M [1 ]
Sanyal, AJ [1 ]
Luketic, VA [1 ]
Shiffman, ML [1 ]
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
81
引用
收藏
页码:181A / 181A
页数:1
相关论文
共 50 条
  • [1] Severe Hepatic Steatosis in Living Donor Liver Transplant Recipients: Clinicopathological Correlation and Outcome
    Jawade, Vaishali Kailash
    Eng, Hock-Liew
    Kuo, Fang-Ying
    Chen, Chao-Long
    Jawade, Kailash K.
    [J]. LIVER TRANSPLANTATION, 2010, 16 (06) : S255 - S256
  • [2] Epidemiology and Risk Factors for Viral Infections in Pediatric Liver Transplant Recipients and Impact on Outcome
    Abdullatif, Hala
    Dhawan, Anil
    Verma, Anita
    [J]. VIRUSES-BASEL, 2023, 15 (05):
  • [3] Hepatic Steatosis is a Risk Factor for the Progression of Hepatitis C Virus in Liver Transplant Recipients
    Julia, Jonathan C.
    Desale, Sameer
    Kallakury, Bhaskar
    Landry, Elizabeth
    Maxwell, Chris J.
    Laurin, Jacqueline
    Satoskar, Rohit
    Fishbein, Thomas
    Shetty, Kirti
    [J]. HEPATOLOGY, 2013, 58 : 1044A - 1044A
  • [4] Impact of Ischaemia Reperfusion Injury and Steatosis in Pre- and Post-Reperfusion Liver Transplant Biopsies On Post Liver Transplant Outcome.
    Sharma, R.
    Ciscar, A.
    Jabri, Y.
    Xystrakis, E.
    Kontis, E.
    Athale, A.
    Srinivasan, P.
    Prachalias, A.
    Huang, X.
    Heaton, N.
    Quaglia, A.
    Ma, Y.
    Jassem, W.
    [J]. TRANSPLANTATION, 2014, 98 : 739 - 739
  • [5] Heparin-induced thrombocytopenia in adult liver transplant recipients: Prevalence and outcome.
    Te, HS
    Conjeevaram, HS
    Shortridge, K
    Faust, TW
    Buell, J
    Cronin, D
    Millis, JM
    Baker, AL
    [J]. HEPATOLOGY, 2000, 32 (04) : 240A - 240A
  • [6] RISK FACTORS FOR THROMBOCYTOPENIA IN LIVER TRANSPLANT RECIPIENTS
    Droc, Gabriela
    Popescu, Mihai
    Tomescu, Dana
    Popescu, Irinel
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 296 - 296
  • [7] Lymphocyte recovery after depletion by alemtuzumab in renal transplant recipients: Impact on outcome.
    Vathsala, A
    Ona, ET
    Tan, SY
    Suresh, S
    Lou, HX
    Casasola, CBC
    Ming, Z
    Machin, D
    Calne, R
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 415 - 415
  • [8] Chronic hepatic allograft rejection: Defining clinical risk factors and assessing impact on graft outcome.
    Wiesner, RH
    Demetris, AJ
    Seaberg, EC
    [J]. HEPATOLOGY, 1998, 28 (04) : 314A - 314A
  • [9] Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of CMV-disease: Risk factors and outcome.
    Salzberger, B
    Bowden, RA
    Hackman, RC
    Davis, C
    Boeckh, M
    [J]. BLOOD, 1996, 88 (10) : 1682 - 1682
  • [10] Very Late-Onset Cytomegalovirus DNAemia in Asymptomatic Kidney Transplant Recipients: Incidence, Risk Factors and Outcome.
    Couzi, L.
    Garrigue, I.
    Bachelet, T.
    Moreau, J.
    Dechanet-Merville, J.
    Merville, P.
    Viot, B.
    [J]. TRANSPLANTATION, 2014, 98 : 765 - 765